| Variable | Effective (n = 36) | Percent |
| Gender |
|
|
| Female | 13 | 36.1 |
| Male | 23 | 63.9 |
| Age |
|
|
| <20 years | 3 | 8.4 |
| 20 - 29 years | 8 | 22.4 |
| 30 - 39 years | 4 | 11.2 |
| 40 - 49 years | 11 | 30.8 |
| 50 - 59 years | 5 | 14 |
| ≥60 years | 5 | 14 |
| Reason for consultation |
|
|
| Lymph node tumefaction | 27 | 75 |
| Other complaints* | 9 | 25 |
| Associated symptoms |
|
|
| General condition altered by fever | 22 | 61.1 |
| Existence of visceromegaly | 13 | 36.1 |
| HIV serology | 10 | 27.8 |
| Pathology diagnosis |
|
|
| Non-Hodgkin lymphoma | 17 | 47.2 |
| Reactional hyperplasia | 10 | 27.8 |
| Infectious lymphadenopathy | 7 | 19.4 |
| Hodgkin lymphoma | 1 | 2.8 |
| Undifferentiated | 1 | 2.8 |